These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 12959298)

  • 1. Biopharmaceutical characterisation of a low-dose (75 mg) controlled-release aspirin formulation.
    Charman WN; Charman SA; Monkhouse DC; Frisbee SE; Lockhart EA; Weisman S; Fitzgerald GA
    Br J Clin Pharmacol; 1993 Nov; 36(5):470-3. PubMed ID: 12959298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of thromboxane A2 but not of systemic prostacyclin by controlled-release aspirin.
    Clarke RJ; Mayo G; Price P; FitzGerald GA
    N Engl J Med; 1991 Oct; 325(16):1137-41. PubMed ID: 1891022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized trial to assess the pharmacodynamics and pharmacokinetics of a single dose of an extended-release aspirin formulation.
    Patrick J; Dillaha L; Armas D; Sessa WC
    Postgrad Med; 2015 Aug; 127(6):573-80. PubMed ID: 25998572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of Bioequivalence Among Low-dose, Enteric-coated Aspirin Preparations.
    Cox D; Fitzgerald DJ
    Clin Pharmacol Ther; 2018 Jun; 103(6):1047-1051. PubMed ID: 28905988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of enteric coating on antiplatelet activity of low-dose aspirin in healthy volunteers.
    Cox D; Maree AO; Dooley M; Conroy R; Byrne MF; Fitzgerald DJ
    Stroke; 2006 Aug; 37(8):2153-8. PubMed ID: 16794200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of a new once-daily controlled-release sarpogrelate hydrochloride compared with immediate-release formulation and the effect of food.
    Kim TE; Kim JR; Jung JA; Kim MJ; Lee SY; Ko JW; Jung WT; Choi YW; Lee HJ; Kim SH; Huh W
    J Clin Pharm Ther; 2014 Apr; 39(2):192-5. PubMed ID: 24325365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In the dose range of 0.5-2.0 mg/kg, acetylsalicylic acid does not affect prostacyclin production in hypertensive pregnancies.
    Vainio M; Mäenpää J; Riutta A; Ylitalo P; Ala-Fossi SL; Tuimala R
    Acta Obstet Gynecol Scand; 1999 Feb; 78(2):82-8. PubMed ID: 10023867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enteric Coating and Aspirin Nonresponsiveness in Patients With Type 2 Diabetes Mellitus.
    Bhatt DL; Grosser T; Dong JF; Logan D; Jeske W; Angiolillo DJ; Frelinger AL; Lei L; Liang J; Moore JE; Cryer B; Marathi U
    J Am Coll Cardiol; 2017 Feb; 69(6):603-612. PubMed ID: 28089180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose aspirin for the prevention of atherothrombosis.
    Patrono C; García Rodríguez LA; Landolfi R; Baigent C
    N Engl J Med; 2005 Dec; 353(22):2373-83. PubMed ID: 16319386
    [No Abstract]   [Full Text] [Related]  

  • 10. PA tablets: investigational compounds combining aspirin and omeprazole for cardioprotection.
    Bliden KP; Brener M; Gesheff MG; Franzese CJ; Tabrizchi A; Tantry U; Gurbel PA
    Future Cardiol; 2013 Nov; 9(6):785-97. PubMed ID: 24180537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presystemic acetylation of platelets by aspirin: reduction in rate of drug delivery to improve biochemical selectivity for thromboxane A2.
    FitzGerald GA; Lupinetti M; Charman SA; Charman WN
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1043-9. PubMed ID: 1762060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-platelet effects of 100 mg alternate day oral aspirin: a randomized, double-blind, placebo-controlled trial of regular and enteric coated formulations in men and women.
    Ridker PM; Hennekens CH; Tofler GH; Lipinska I; Buring JE
    J Cardiovasc Risk; 1996 Apr; 3(2):209-12. PubMed ID: 8836865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic and pharmacodynamic differences between two low dosages of aspirin may affect therapeutic outcomes.
    Cerletti C; Dell'Elba G; Manarini S; Pecce R; Di Castelnuovo A; Scorpiglione N; Feliziani V; de Gaetano G
    Clin Pharmacokinet; 2003; 42(12):1059-70. PubMed ID: 12959636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin resistance.
    Tantry US; Mahla E; Gurbel PA
    Prog Cardiovasc Dis; 2009; 52(2):141-52. PubMed ID: 19732606
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacokinetics of low-dose oral modified release, soluble and intravenous aspirin in man, and effects on platelet function.
    Bochner F; Williams DB; Morris PM; Siebert DM; Lloyd JV
    Eur J Clin Pharmacol; 1988; 35(3):287-94. PubMed ID: 3181281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of 50 mg enteric-coated aspirin (Astrix) on thromboxane and prostacyclin synthesis.
    James MJ; Walsh JA; Foreman RK
    Aust N Z J Surg; 1987 Oct; 57(10):763-6. PubMed ID: 3322248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of enteric-coated aspirin and inhibition of platelet thromboxane A2 and vascular prostacyclin generation in humans.
    Cerletti C; Marchi S; Lauri D; Domanin M; Lorenzi G; Urso R; Dejana E; Latini R; de Gaetano G
    Clin Pharmacol Ther; 1987 Aug; 42(2):175-80. PubMed ID: 3301151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The administration of a loading dose of aspirin to patients presenting with acute myocardial infarction while receiving chronic aspirin treatment reduces thromboxane A2-dependent platelet reactivity.
    Santos MT; Madrid I; Moscardo A; Latorre AM; Bonastre J; Ruano M; Valles J
    Platelets; 2014; 25(4):268-73. PubMed ID: 23909754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preservation of bioavailability of ingredients and lack of drug-drug interactions in a novel five-ingredient polypill (polycap): a five-arm phase I crossover trial in healthy volunteers.
    Patel A; Shah T; Shah G; Jha V; Ghosh C; Desai J; Khamar B; Chakraborty BS
    Am J Cardiovasc Drugs; 2010; 10(2):95-103. PubMed ID: 20334446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Durlaza--a 24-hour extended-release aspirin.
    Med Lett Drugs Ther; 2016 Jan; 58(1486):7. PubMed ID: 26761340
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.